Does tocilizumab mean the end of glucocorticoids in giant cell arteritis?

被引：1
|
作者：
Samson, M. [1 ,2 ,3 ]
Bonnotte, B. [1 ,2 ,3 ]
机构：
[1] CHU Dijon Bourgogne, Serv Med Interne, 2 Blvd Mal de Lattre de Tassigny, F-21000 Dijon, France
[2] CHU Dijon Bourgogne, Immunol Clin, 2 Blvd Mal de Lattre de Tassigny, F-21000 Dijon, France
[3] Univ Bourgogne Franche Comte, FHU Increase, Inserm U1098, F-21000 Dijon, France
来源：
REVUE DE MEDECINE INTERNE | 2018年 / 39卷 / 02期
关键词：
Giant cell arteritis; Treatment; Tocilizumab; LARGE-VESSEL VASCULITIS; TAKAYASU ARTERITIS; DOUBLE-BLIND; THERAPY; TRIAL; ABATACEPT;
D O I：
10.1016/j.revmed.2017.11.003
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：75 / 77
页数：3
相关论文
共 50 条
  • [1] Tocilizumab and glucocorticoids for giant cell arteritis: the learning curve
    Mackie, Sarah L.
    Bhogal, Rayna
    LANCET RHEUMATOLOGY, 2023, 5 (12): : e703 - e705
  • [2] Tocilizumab in giant cell arteritis
    Thorley, Jennifer
    LANCET RHEUMATOLOGY, 2021, 3 (02): : E100 - E100
  • [3] Tocilizumab in Giant Cell Arteritis
    Pflugfelder, J.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2017, 76 (01): : 87 - 88
  • [4] Tocilizumab for giant cell arteritis
    Antonio, Aileen A.
    Santos, Ronel N.
    Abariga, Samuel A.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022, (05):
  • [5] Tocilizumab in Giant Cell Arteritis
    Mariano, Vincent J.
    Frishman, William H.
    CARDIOLOGY IN REVIEW, 2018, 26 (06) : 321 - 330
  • [6] Tocilizumab for giant cell arteritis
    Antonio, Aileen A.
    Santos, Ronel N.
    Abariga, Samuel A.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (08):
  • [7] Does Tocilizumab Influence Ophthalmic Outcomes in Giant Cell Arteritis?
    Bouffard, Marc A.
    Prasad, Sashank
    Unizony, Sebastian
    Costello, Fiona
    JOURNAL OF NEURO-OPHTHALMOLOGY, 2022, 42 (02) : 173 - 179
  • [8] Tocilizumab (Actemra) for Giant Cell Arteritis
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2017, 59 (1530): : 161 - 162
  • [9] Tocilizumab for the treatment of giant cell arteritis
    Schirmer, Michael
    Muratore, Francesco
    Salvarani, Carlo
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2018, 14 (05) : 339 - 349
  • [10] Tocilizumab in the treatment of giant cell arteritis
    Leuchten, Nicolai
    Aringer, Martin
    IMMUNOTHERAPY, 2018, 10 (06) : 465 - 472
12345